Latest News
-
HBS Reporting
Illumina launches multiple-gene test to spot rare treatable cancers
Mar 17, 2022March 15 (Reuters) – Genome sequencing group Illumina (ILMN.O) on Tuesday launched a cancer test in...
-
HBS Reporting
Masks, PCR tests no longer needed in Namibia as COVID cases fall
Mar 17, 2022WINDHOEK, March 15 (Reuters) – The wearing of masks in public in Namibia and negative PCR...
-
HBS Reporting
Omicron linked to rise in croup in babies; TB vaccine improves immune response to coronavirus
Mar 17, 2022March 16 (Reuters) – The following is a summary of some recent studies on COVID-19. They...
-
HBS Reporting
Analysis: China’s COVID governance under pressure as Omicron spreads
Mar 17, 2022Summary* China hit by biggest wave of cases since 2020 Wuhan outbreak* Parts of China feeling...
-
HBS Reporting
Bristol, Nektar to terminate melanoma therapy trials after study fails (March 14)
Mar 17, 2022March 14 (Reuters) – (This March 14 story corrects 4th paragraph to say company had $800...
-
HBS Reporting
Moderna patent application raises fears for Africa COVID vaccine hub
Mar 17, 2022SUMMARY * Africa hub firm says patent will impede freedom to operate* Moderna says patents will...
-
HBS Reporting
New U.S. FDA chief says he will prioritize fighting misinformation
Mar 17, 2022WASHINGTON, Feb 17 (Reuters) – Misinformation about science is increasingly prevalent and a significant public health...
-
HBS Reporting
Carnival Cruise Line to ease mask mandate for guests from March 1
Mar 17, 2022Feb 18 (Reuters) – Carnival Cruise Line plans to make masks optional for its guests from...
-
HBS Reporting
UK must cut spending on COVID testing, Johnson says
Mar 17, 2022LONDON, Feb 20 (Reuters) – Britain wants to retain the capability to spot new coronavirus variants...
-
HBS Reporting
UK’s Johnson scraps COVID restrictions in England
Mar 17, 2022Summary* Self-isolation law to be scrapped in England* End to free testing in April* Johnson bets...